InfuSystem Holdings (INFU) Non-Current Debt (2010 - 2026)
InfuSystem Holdings (INFU) posted Non-Current Debt of $19.6 million for Q1 2026, little changed on a QoQ basis from $19.6 million in Q4 2025, and down 31.56% year-over-year from $28.7 million in Q1 2025.
InfuSystem Holdings (INFU) Non-Current Debt (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Non-Current Debt history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.
- Quarterly Non-Current Debt fell 31.56% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (down 31.56% YoY) and the FY2025 annual result came in at $19.6 million, down 17.76% from the prior year.
- Non-Current Debt was $19.6 million for Q1 2026 at InfuSystem Holdings, roughly flat from $19.6 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $36.4 million in Q1 2023 and bottomed at $19.6 million in Q4 2025.
- A 5-year average of $29.5 million and a median of $29.9 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt advanced 11.54% — and 2026, when it tumbled 31.56%.
- InfuSystem Holdings' Non-Current Debt stood at $33.2 million in 2022, then slipped by 12.23% to $29.1 million in 2023, then declined by 18.0% to $23.9 million in 2024, then declined by 17.76% to $19.6 million in 2025, then grew by 0.11% to $19.6 million in 2026.
- Business Quant data shows INFU's Non-Current Debt at $19.6 million in Q1 2026, $19.6 million in Q4 2025, and $20.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 19.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.65 Mn |
| Dec 31, 2025 | 19.63 Mn |
| Sep 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 26.35 Mn |
| Mar 31, 2025 | 28.71 Mn |
| Dec 31, 2024 | 23.86 Mn |
| Sep 30, 2024 | 27.98 Mn |
| Jun 30, 2024 | 34.17 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 29.10 Mn |
| Sep 30, 2023 | 32.66 Mn |
| Jun 30, 2023 | 36.14 Mn |
| Mar 31, 2023 | 36.39 Mn |
| Dec 31, 2022 | 33.16 Mn |
| Sep 30, 2022 | 34.46 Mn |
| Jun 30, 2022 | 33.69 Mn |
| Mar 31, 2022 | 34.79 Mn |
| Dec 31, 2021 | 32.75 Mn |
| Sep 30, 2021 | 30.90 Mn |
| Jun 30, 2021 | 31.94 Mn |